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Abstract
Background: In polymorphonuclear leukocytes (PMNL), mobilization of calcium ions is one of the
early events triggered by binding of chemoattractant to its receptors. Besides chemotaxis, a variety
of other functional responses are dependent on calcium ion mobilization. PMNL from chronic
myeloid leukaemia (CML) patients that were morphologically indistinguishable from normal PMNL
were found to be defective in various functions stimulated by a chemoattractant – fMLP. To study
the mechanism underlying defective functions in CML PMNL, we studied calcium mobilization in
CML PMNL in response to two different classical chemoattractants, fMLP and C5a.
Results: Release of calcium estimated by flow cytometry and spectrofluorimetry using fluo-3 as an
indicator showed that the [Ca2+]i levels were lower in CML PMNL as compared to those in normal
PMNL. But, both normal and CML PMNL showed maximum [Ca2+]i in response to fMLP and C5a
at 10 sec and 30 sec, respectively. Spectrofluorimetric analysis of the total calcium release in
chemoattractant treated PMNL indicated more and faster efflux of [Ca2+]i in CML PMNL as
compared to normal PMNL.
Conclusion: Fine-tuning of Ca2+ homeostasis was altered in CML PMNL. The altered Ca2+
homeostasis may contribute to the defective functions of CML PMNL.
Background
In polymorphonuclear leukocytes (PMNL), changes in
intracellular calcium, i.e. [Ca2+]i are associated with multi-
ple cellular events, including activation of cellular kinases
and phosphatases, degranulation, phagosome-lysosome
fusion, regulation of cytoskeleton binding proteins, tran-
scriptional control and modulation of surface receptors
[1]. Migration of leukocytes through the extracellular
matrix to the site of action is the first step in host defence
and role of calcium in this process is well reviewed by
Maxfield [2]. Although no stable [Ca2+]i gradients were
detected in migrating human PMNL, a transient global
increase in [Ca2+]i was found to be important for chemo-
taxis [3]. PMNL migration can be induced by binding of
chemoattractants to their receptors present on PMNL sur-
face. The classical chemoattractants for PMNL are n-
formyl peptides that are analogous to bacterial secretion
[4] and anaphylatoxin C5a, which is formed upon com-
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peptides and C5a are present on PMNL and they share
common structural motifs [6]. Mobilization of [Ca2+]i is
one of the early events triggered by binding of a chemoat-
tractant to its receptor.
Chronic myeloid leukaemia (CML) is a clonal, pluoripo-
tent stem cell disorder characterized by the occurrence of
Philadelphia chromosome (Ph1) and presence of a large
number of mature and immature myeloid cells in the
peripheral blood [7]. Earlier work from our laboratory has
shown that PMNL from CML patients were defective in
actin dependent functions such as chemotaxis, degranula-
tion, endocytosis, etc. [8-12]. Chemotaxis was found to be
defective in all the phases of the disease [9]. Calcium plays
a central role in these functions. Calcium regulates cell
motility by regulating polymerization of actin – one of the
major motile machinery proteins in PMNL. Increased
[Ca2+]i levels lead to fragmentation of actin network by
disrupting the cross bridges of actin network. Increased
[Ca2+]i levels cause fragmentation of F-actin by activation
of actin severing and capping proteins such as gelsolin
and macrophage capping protein [13]. Fibroblasts trans-
fected with gelsolin, a calcium activated actin severing and
capping protein, display increased motility [14]. In view
of the role of calcium in various motility related events,
the present studies are aimed to study mobilization of
Ca2+ in CML PMNL. Mobilization of Ca2+ by fMLP and
C5a was studied in these cells. PMNL from healthy nor-
mal individuals were used as control. We found that fine-
tuning of Ca2+ homeostasis in CML PMNL was altered as
compared to that in normal PMNL.
Results
Measurement of [Ca2+]i by flow cytometry
Basal [Ca2+]i levels in PMNL
Fluo-3 loaded normal PMNL showed a broad bell shaped
plot, indicating considerable variation in the basal [Ca2+]i
levels of the normal PMNL population (Fig. 1). Fluo-3
loaded unstimulated CML PMNL showed a broad plot
with a long tail near Y-axis, containing 9–10% of the pop-
ulation. Thus, 10% of the population had very low levels
of [Ca2+]i. Comparison between the two populations
showed that basal levels of [Ca2+]i in CML PMNL were
lower and showed more variation. However, this differ-
ence was not statistically significant (Table 1).
Stimulation with fMLP
In fMLP stimulated normal PMNL, plots were negatively
skewed and broader. Hence the heterogeneity in the
PMNL population with respect to [Ca2+]i levels increased.
On stimulation, the peaks shifted to right (Fig. 1A; c, d, e)
leading to a significant increase in [Ca2+]i levels at 10 sec,
30 sec, and 60 sec (Table 1 and Fig. 2), maximum increase
in [Ca2+]i being at 10 sec. On further treatment of these
cells with calcium ionophore A23187, [Ca2+]i levels
increased significantly (Fig. 1A; f, Table 1), but heteroge-
neity in PMNL with respect to [Ca2+]i decreased. Addition
of EGTA resulted in building up of a small peak towards
extreme left on the X-axis indicating that only 8–10% of
the total population, was sensitive to EGTA (Fig. 1A; g).
But the resulting decrease in total [Ca2+]i levels was con-
siderable. On further addition of MnCl2, [Ca2+]i levels
decreased significantly and were below the basal levels
(Fig. 1A; h, Table 1). The PMNL population was extremely
heterogeneous as far as sensitivity to quenching of cal-
cium by MnCl2 was considered.
To compare the extent of stimulation in PMNL, the ratio
of [Ca2+]i levels before and after fMLP stimulation were
calculated. In normal PMNL, 10 sec of fMLP treatment
resulted in 1.25 to 4.4 times (mean ± SEM = 1.6 ± 0.21)
increase in [Ca2+]i over the basal levels. Further treatment
with ionophore increased the mean ratio to 2.5 ± 0.36.
Subsequent addition of EGTA and MnCl2 decreased
[Ca2+]i levels to 21% and 64% of the maximum levels,
respectively; ultimately quenching down the fluorescence
to about 30% lower than the basal levels (Fig. 3).
CML PMNL showed narrowing of the PMNL peak after
fMLP stimulation, indicating decrease in heterogeneity in
the population with respect to [Ca2+]i levels (Fig. 1C; b, c,
d, e). At all the time points studied after fMLP stimulation,
levels of [Ca2+]i were significantly higher than the basal
[Ca2+]i levels (Table 1, Fig. 2). The peak levels were seen at
10 sec. On further treatment of these cells with calcium
ionophore A23187, the [Ca2+]i levels increased further,
but shape of the peak was unaltered (Fig. 1C; f). On addi-
tion of EGTA, the total [Ca2+]i content in the population
was not altered considerably (Fig. 1C; g). On further addi-
tion of MnCl2, the peak width increased, the peak shifted
towards Y-axis and an additional very small peak
appeared adjacent to Y-axis (Fig. 1C; h). Thus, the PMNL
population was extremely heterogeneous as far as sensitiv-
ity to quenching of calcium by MnCl2 was considered. The
ratio of maximum fluorescence in fMLP stimulated cells
ranged from 1.42 to 5.62. On addition of ionophore the
mean ratio increased to 2.6. Addition of EGTA led to 10%
decrease in the fluorescence intensity where as MnCl2
resulted in a statistically significant 60% decrease as com-
pared to the maximum fluorescence intensity. Thus, EGTA
and MnCl2 together brought down the fluorescence to the
basal level (Fig. 3).
Both, normal and CML PMNL, showed significantly
higher [Ca2+]i levels on fMLP stimulation as compared to
that in the respective unstimulated PMNL(Fig. 1A and
1C). But on fMLP stimulation, the heterogeneity with
respect to [Ca2+]i levels was lower in CML PMNL than in
normal PMNL. The [Ca2+]i levels both before and afterPage 2 of 14
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PMNL. However, this difference was not statistically sig-
nificant. In fMLP stimulated CML PMNL, the drop in lev-
els of [Ca2+]i at 60 sec was rapid and more as compared to
that in normal PMNL. This was evident from the higher
ratio over the basal level at 60 sec in normal PMNL as
compared to that in CML PMNL. On the addition of cal-
cium ionophore A23187, fMLP stimulated CML PMNL
showed lower levels of [Ca2+]i as compared to normal
PMNL. But the extent of [Ca2+]i mobilization was higher
in CML as reflected in the ratios (Fig. 3). Though the
extent of [Ca2+]i stimulation with fMLP and ionophore
was higher in CML PMNL than that in normal, it was not
statistically significant.
Quenching of [Ca2+]i with EGTA showed considerable
decrease in [Ca2+]i levels in normal PMNL but not in CML
PMNL. On further quenching of [Ca2+]i by MnCl2, the
[Ca2+]i levels were maintained above the basal levels in
CML PMNL whereas, in normal PMNL these were lower
than the basal levels (Table 1). Significant quenching of
[Ca2+]i is seen on addition of MnCl2 in both the popula-
tions. When ratios of these EGTA and MnCl2 treated nor-
mal and CML populations were compared they were
significantly higher in CML PMNL than the respective nor-
mal PMNL. Thus, it shows that though the levels of [Ca2+]i
and quenching of [Ca2+]i were always lower in CML
PMNL, the extent of stimulation, i.e. the ratios of these
[Ca2+]i levels to the basal levels were maintained at higher
levels in CML PMNL as compared to that in normal
PMNL.
Stimulation with C5a
C5a stimulated normal PMNL showed broad negatively
skewed peaks (Fig. 1B; c, d, e). The [Ca2+]i levels were sig-
nificantly higher than the basal [Ca2+]i levels. The maxi-
mum increase was at 30 sec after C5a stimulation (Fig. 2
and Table 2). Treatment of these cells with calcium iono-
phore A23187 resulted into two peaks. A major peak was
seen with a modal channel shifted to right as compared to
that seen at 30 sec (Fig. 1B; f), indicating a further increase
in [Ca2+]i levels. A small population of PMNL that formed
a minor peak was probably non-respondent to the iono-
phore treatment. The addition of EGTA resulted in a sig-
nificant shift of the modal channel of the major peak to
the left and its broadening (Fig. 1B; g). This showed
increased heterogeneity in normal PMNL with respect to
quenching of [Ca2+]i by EGTA.
Though after EGTA treatment, [Ca2+]i levels reduced sig-
nificantly than that in ionophore treated PMNL, they
remained at a significantly higher level than the basal
[Ca2+]i levels (Table 2). On further addition of MnCl2, the
major peak broadened further and both the peaks shifted
towards Y-axis showing heterogeneity in the PMNL popu-
lation as far as sensitivity to quenching of calcium by
MnCl2 was considered (Fig. 1B; h). After MnCl2 treatment
the [Ca2+]i levels reached below the basal [Ca2+]i levels and
these were significantly lower than that in ionophore
treated PMNL. To compare the extent of stimulation in
PMNL, the ratio of [Ca2+]i levels before and after C5a stim-
ulation was calculated. In normal PMNL, it ranged from
1.2 to 2.89. On further treatment with ionophore though
the mean ratio increased to 2.57 ± 0.25, this increase was
not statistically significant. Further additions of EGTA and
MnCl2 led to 14% and 55% quenching of fluorescence.
This decrease in fluorescence was statistically significant
(Fig. 3 and Table 2).
C5a stimulated CML PMNL showed negatively skewed
peaks that were shifted towards right (Fig. 1D; c, d, e).
These increases in [Ca2+]i levels after C5a stimulation were
significantly higher than the basal [Ca2+]i levels. Maxi-
mum increase in the [Ca2+]i levels was seen at 30 sec after
C5a stimulation (Fig. 2 and Table 2). On treatment of
these cells with calcium ionophore A23187 [Ca2+]i levels
increased further. The addition of EGTA resulted in the
building up of an extended tail on the left side of the peak
indicating heterogeneity in PMNL population as far as
sensitivity to quenching of calcium by EGTA was consid-
ered. About 20% of the total population was lying in this
tail and hence the decrease in total [Ca2+]i levels was con-
siderable (Table 2). On further addition of MnCl2, a major
bell shaped peak along with a minor peak towards
extreme left was seen (Fig. 1D; g). Thus, PMNL population
was extremely heterogeneous as far as sensitivity to
Table 1: Flow cytometric estimation of [Ca2+]i in fMLP stimulated normal and CML PMNL.
Stimulant n Nil (Basal level) fMLP
Time 10 s 30 s 60 s Calcium ionophore EGTA MnCl2
Normal 25 291.24 ± 53.95 472.15# ± 106.93 466.93# ± 158.45 339.34# ± 69.58 728.07# ± 155.05 601.76# ± 155.55 193.14$ ± 39.20
CML 27 236.69 ± 22.33 412.31# ± 106.52 384.76# ± 88.21 248.15# ±64.75 610.28# ± 158.6 601.84# ± 164.83 240.32# ± 75.77
All values are average ± SEM
n = Number of samples. 
# Significantly higher value over the respective basal level, p < 0.05. 
$ Significantly lower value as compared to the basal level, p < 0.05.Page 3 of 14
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Flow cytometric histogram overlay of fluo-3 loaded PMNLigure 1
Flow cytometric histogram overlay of fluo-3 loaded PMNL. Representative plots of fMLP or C5a stimulated PMNL 
from normal donors (A and B) and CML patients (C and D). (a) isotype, (b) unstimulated, stimulated with fMLP or C5a for (c) 
10 sec, (d) 30 sec, (e) 60 sec, (f) calcium ionophore A23187, (g) EGTA and (h) MnCl2. X-axis indicates fluorescence channel 
No. and Y-axis indicates No. of cells.
Molecular Cancer 2006, 5:65 http://www.molecular-cancer.com/content/5/1/65quenching of calcium by MnCl2 was considered. This fur-
ther reduced [Ca2+]i levels to considerably lower levels
(Table 2). In CML PMNL the ratio over basal level ranged
from 1.45 to 3.77. Though addition of ionophore
increased the mean ratio to 2.71 ± 0.23, it was not statis-
tically significant. In contrast to this, sequential addition
of EGTA and MnCl2 decreased the fluorescence intensity
significantly, by 15% and 58%, respectively (Fig. 3).
Both normal and CML PMNL showed significantly higher
[Ca2+]i levels on C5a stimulation as compared to the
respective basal [Ca2+]i levels. But the heterogeneity with
respect to [Ca2+]i levels was higher in CML PMNL. Though
at 10 sec after C5a stimulation the levels of [Ca2+]i, were
comparable in normal and CML PMNL, at later time
points these were higher in normal PMNL. However,
these differences were not statistically significant. Maxi-
mum stimulation was seen at 30 sec in both the popula-
tions. In CML PMNL the [Ca2+]i levels increased by 2.33
times whereas in normal PMNL it increased by 2.13 times
the basal level (Table 2 and Fig. 3). The extents of stimu-
lation were higher in C5a stimulated CML PMNL at 10 sec
and 30 sec as compared to normal PMNL. At 60 sec, a
steep decrease in [Ca2+]i levels was seen in CML PMNL
while in normal PMNL it was gradual. This resulted in
reversing the scenario (Fig. 3). On addition of calcium
ionophore A23187 subsequent to C5a stimulation, CML
PMNL showed a lower amount of [Ca2+]i as compared to
normal PMNL (Table 2). But extent of stimulation was
higher in CML PMNL than that in normal PMNL. How-
ever, this was not statistically significant. Similarly differ-
ences in the decrease in the [Ca2+]i by EGTA and MnCl2 in
normal and CML PMNL were non-significant (Table 2,
Fig. 3).
In both CML and normal PMNL, the [Ca2+]i levels in C5a
stimulated PMNL were higher than fMLP stimulated
PMNL. The maximum [Ca2+]i levels were seen at 10 sec
and 30 sec after fMLP and C5a stimulation, respectively
(Fig. 2). When the maximum [Ca2+]i levels obtained by
treatment of PMNL with calcium ionophore A23187 and
minimum [Ca2+]i levels obtained by quenching with
EGTA and MnCl2, in fMLP and C5a stimulated normal
and CML PMNL were compared, they were not signifi-
cantly different. Thus, though levels of [Ca2+]i seen in
fMLP and C5a stimulated normal and CML PMNL dif-
fered, the behavioural pattern, i.e. mode of alterations in
[Ca2+]i levels with respect to time, was similar in both the
populations.
Measurement of total Ca2+ by spectrofluorimetry
Mobilization of [Ca2+]i eventually leads to efflux of
[Ca2+]i. Therefore, to estimate total mobilization of Ca2+
we have quantitated Ca2+ levels in fluo-3 loaded normal
and CML PMNL by spectrofluorimetry.
Basal Ca2+ levels in PMNL
The basal levels of Ca2+ in normal PMNL ranged from 224
to 386 nM whereas in CML PMNL it ranged from 175 to
342 nM. As seen in flow cytometric assay the basal levels
Flow cytometric estimation of [Ca2+]i levels in PMNLigure 2
Flow cytometric estimation of [Ca2+]i levels in PMNL. Fluo-3 loaded CML and normal PMNL were stimulated with 
fMLP (10-8 M) or C5a (10-9 M) followed by treatment with calciumionophore A23187, EGTA, and MnCl2. X-axis indicates the 
treatment given to the cells and Y-axis indicates average median fluorescence channel values.Page 5 of 14
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normal PMNL (Table 3). However, this difference was sta-
tistically non-significant.
Stimulation with fMLP
On fMLP stimulation of normal PMNL, the total amount
of Ca2+ increased significantly at 10 sec and 30 sec as com-
pared to the basal levels; whereas at 60 sec it was signifi-
cantly lower as compared to the basal level (Table 3). Peak
Ca2+ levels were seen at 10 sec (Fig. 4). To compare the
extent of stimulation in PMNL, the ratio of Ca2+ levels
before and after fMLP stimulation were calculated. In nor-
mal PMNL, this ratio ranged from 1.2 to 2.09 (Fig. 5). On
addition of EGTA little quenching of the fluo-3 fluores-
cence was seen as compared to the fluorescence intensity
of the calcium ionophore A23187 treated cells. However,
the levels of Ca2+ were still significantly higher as com-
pared to the basal levels. The ratio of the two was 1.11 ±
0.23. On addition of MnCl2, a significant quenching of
fluorescence occurred, bringing down the ratio to 0.44 ±
0.11 (Fig. 5).
In CML PMNL, the total amount of Ca2+ was significantly
higher at 10 sec and 30 sec after fMLP stimulation as com-
pared to basal levels. Whereas at 60 sec, Ca2+ levels were
higher than the basal level but it was statistically non-sig-
nificant. Peak Ca2+ levels were seen at 10 sec (Table 3 and
Fig. 4). This was also evident from the ratio over the basal
level at different time points after fMLP stimulation,
which ranged from 1.45 to 2.70. Similar to normal PMNL,
about 30% quenching of fluo-3 was seen on the addition
of EGTA as compared to the [Ca2+]i levels achieved after
Flow cytometric estimation of extent of stimulation of [Ca2+]i in PMNLigure 3
Flow cytometric estimation of extent of stimulation of [Ca2+]i in PMNL. Fluo-3 loaded CML and normal PMNL were 
stimulated with fMLP (10-8 M) or C5a (10-9 M), followed by treatment with calcium ionophore A23187, EGTA and MnCl2. X-
axis indicates the treatment given to the cells and Y-axis indicates ratios of average [Ca2+]i levels in stimulated cells to the 
[Ca2+]i levels in unstimulated cells, i.e. basal level.Page 6 of 14
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times higher than the basal levels. This difference between
Ca2+ levels was statistically significant. On addition of
MnCl2 the Ca2+ levels decreased significantly, lowering
down the ratio to 0.46 ± 0.06 (Fig. 5).
In fMLP stimulated CML PMNL, the Ca2+ levels as well as
extent of stimulation were higher than those in normal
PMNL (Fig. 5). However, the differences between the two
populations were statistically non-significant. The drop in
Ca2+ levels after reaching the peak levels was higher in
CML PMNL as compared to that in normal PMNL. But,
since the Ca2+ levels had reached much higher in CML
PMNL as compared to normal PMNL these remained
higher than the basal levels for a longer time.
Stimulation with C5a
In normal PMNL, total amount of Ca2+ was significantly
higher at all the time points after C5a stimulation as com-
pared to the basal levels, the peak Ca2+ levels being at 10
sec (Table 4 and Fig. 4). The ratio of Ca2+ levels of C5a
stimulated normal PMNL over basal Ca2+ levels ranged
from 1.25 to 2.56. On addition of EGTA, little quenching
of the fluo-3 fluorescence was seen as compared to the flu-
orescence intensity of the calcium ionophore A23187
treated cells. Though the levels of Ca2+ were higher as
compared to the basal levels, they were statistically non-
significant.  The ratio of the two was 1.22 ± 0.33 (Fig. 5).
On addition of MnCl2, a significant quenching of fluores-
cence occurred lowering down the ratio to 0.59 ± 0.12
(Fig. 5). 
Similar to normal PMNL, CML PMNL showed signifi-
cantly higher Ca2+ levels on C5a stimulation that peaked
at 10 sec (Table 4 and Fig. 4). In these cells, the ratio over
basal Ca2+ levels ranged from 1.69 to 2.75. Quenching of
fluo-3 was seen on addition of EGTA as compared to the
fluorescence intensity of the ionophore treated cells. The
Ca2+ levels were 1.57 ± 0.33 times higher than the basal
levels. However, this difference was not statistically signif-
icant. On further addition of MnCl2, the Ca2+ levels
decreased significantly, thereby reducing the ratio to 0.73
± 0.12 (Fig. 5). Thus on C5a stimulation, both, CML and
normal PMNL showed significant increase in the Ca2+ lev-
els reaching maximum at 10 sec (Table 4). The concentra-
tion of Ca2+ and extent of stimulation were higher in CML
PMNL as compared to that in normal PMNL (Fig. 4). But
these differences were not statistically significant. The
drop in Ca2+ concentrations after reaching the peak stim-
ulation was rapid and more in CML PMNL as compared
to that in normal PMNL (Fig. 4).
In normal PMNL, at all the time points after stimulation
the levels of Ca2+ were higher in C5a stimulated PMNL
than that in fMLP stimulated PMNL (Fig. 4 and Table 4).
In CML PMNL, at 10 sec and 30 sec after stimulation Ca2+
levels were higher in fMLP stimulated PMNL than those in
C5a stimulated PMNL. At 60 sec calcium levels were
higher in C5a stimulated CML PMNL as compared to
fMLP stimulated CML PMNL (Fig. 4 and Table 4). Thus,
alterations were seen in the levels and time kinetics of
Ca2+ mobilization in CML PMNL in response to fMLP and
C5a stimulation. Levels of Ca2+ reached after addition of
Table 3: Spectrofluorimetric estimation of Ca2+ in fMLP stimulated normal and CML PMNL.
Stimulant n Nil (Basal level) fMLP
Time 10 s 30 s 60 s EGTA MnCl2
Normal 25 304.74 ± 75.78 467.34# ± 97.99 373.88# ± 56.58 275.06# ± 24.46 339.60# ± 31.70 135.39$ ± 21.03
CML 27 285.48 ± 34.13 692.65# ± 95.92 488.17# ± 89.92 334.66 ± 79.09 366.30# ± 51.64 132.14$ ± 19.60
All values are average ± SEM, in nM. 
n = Number of samples. 
# Significantly higher value over the respective basal level, p < 0.05. 
$ Significantly lower value as compared to the basal level, p < 0.05.
Table 2: Flow cytometric estimation of [Ca2+]i in C5a stimulated normal and CML PMNL.
Stimulant n Nil (Basal level) C5a
Time 10 s 30 s 60 s Calcium ionophore EGTA MnCl2
Normal 20 293.94 ± 46.48 535.84# ± 102.31 626.19# ± 166.79 556.62# ± 114.85 757.45# ± 106.95 510.05# ± 96.67 256.52$ ± 51.12
CML 21 237.05 ± 36.44 532.58# ± 108.54 552.20# ± 94.31 378.60 ± 70.98 642.25# ±162.82 586.81 ± 157.76 284.99# ± 103.32
All values are average ± SEM. 
n = Number of samples. 
# Significantly higher value over the respective basal level, p < 0.05. 
$ Significantly lower value as compared to the basal level, p < 0.05.Page 7 of 14
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PMNL as compared to that in C5a stimulated PMNL
(Table 3 and 4). However, this difference was statistically
non-significant. Thus, flow cytometric and spectrofluori-
metric estimation of Ca2+, indicated a rapid and greater
efflux of [Ca2+]i in CML PMNL as compared to that in nor-
mal PMNL. But in spite of more efflux of [Ca2+]i, the
[Ca2+]i levels in CML PMNL after stimulation were main-
tained above the basal level. Whereas in normal PMNL,
the [Ca2+]i levels after stimulation either dropped down
below basal level or were slightly higher. In summary, the
fine-tuning of Ca2+ homeostasis is altered in CML PMNL
as compared to that in normal PMNL.
Discussion
Binding of the chemoattractants to their receptors on
PMNL transmits signals across the plasma membrane, ini-
tiating phosphophorylation cascade and changes in
[Ca2+]i concentration, that are crucial to cell activation.
Both the release of calcium from the intracellular stores
and the influx of calcium from the extracellular space con-
tribute to the rise in [Ca2+]i levels. This [Ca2+]i in turn reg-
ulates chemoattractant receptor availability in PMNL [15].
Calcium from the extracellular space enters the cell cyto-
plasm through various types of channels, i.e. voltage oper-
ated Ca2+ channels (VOCCs), ligand-gated non-specific
cation channels (LGCCs) and receptor-activated Ca2+
channels (RACCs). Calcium can also be released from
internal Ca2+ stores through inositol 1,4,5-triphosphate
(IP3) or ryanodine receptors and is replenished by store-
operated channels (SOCs) (Fig. 6) [16]. Presence of ryan-
odine-sensitive calcium stores that might be involved in
receptor mediated chemotaxis has been reported in
human PMNL [17].
During chemotaxis localised increases in [Ca2+]i occur.
Two distinct [Ca2+]i storage sites have been identified in
PMNL. One site was located peripherally under the
plasma membrane and the other in the juxtanuclear
space. The central [Ca2+]i storage site released [Ca2+]i in
response to fMLP, whereas engagement and clustering of
CD11b/CD18 integrins caused [Ca2+]i release from the
peripheral stores [18]. The peripheral stores of [Ca2+]i are
known to be regulated by the cytoskeleton interactions
[19]. The rise in cytosolic [Ca2+]i concentration is caused
by the mobilization of Ca2+ from intracellular stores to the
cytosol followed by an immediate increase in plasma
membrane permeability to extracellular calcium. Efflux of
[Ca2+]i is mediated by calmodulin dependent calcium
adenosine triphosphatase (Ca-ATPase). Ca-ATPase proba-
bly serves as the regulatory and homeostatic mechanism
Total Ca2+ levels estimated by spectrofluorimetric assayFigure 4
Total Ca2+ levels estimated by spectrofluorimetric assay. CML and normal PMNL were stimulated with fMLP (10-8 M) 
or C5a (10-9 M) and the changes in calcium levels measured at 10 sec, 30 sec and 60 sec. The PMNL were further treated with 
10 μM calcium ionophore A23187, EGTA, and MnCl2. The fluorescence of the fluo-3 loaded PMNL was measured in arbitrary 
fluorescence units. X-axis indicates the treatment given to the cells and Y-axis indicates the average of the total calcium in nMPage 8 of 14
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the cytosolic [Ca2+]i concentration is increased either by
fMLP or ionophore, efflux of [Ca2+]i from the cell occurs
as a result of calmodulin mediated activation of Ca-
ATPase [20].
Mobilization of Ca2+ is upstream to various biochemical
and functional events stimulated in PMNL by various che-
moattractants. Therefore, to understand the mechanism
of various defects seen in CML PMNL, we have studied
mobilization of Ca2+ in response to chemoattractant stim-
ulation. The intracellular free calcium and the total cal-
cium release, i.e. calcium released intracellularly and
extracellularly were studied in CML PMNL in comparison
to normal PMNL.
Our studies showed altered calcium homeostasis in CML
PMNL. The analysis of fluo-3 loaded normal and CML
PMNL showed heterogeneity with respect to the basal
[Ca2+]i levels and [Ca2+]i levels reached after stimulation.
On further stimulation of the chemoattractant stimulated
PMNL with calcium ionophore, the heterogeneity in
[Ca2+]i levels decreased. Vast heterogeneity was seen in
PMNL with respect to the sensitivity of quenching of
[Ca2+]i by EGTA and MnCl2. Similar heterogeneity was
reported earlier. Elsner et al reported heterogeneity in
[Ca2+]i levels in human PMNL [21]. Additionally, Elsner et
al demonstrated heterogeneity in signal transduction
pathways leading to mobilization of cytosolic calcium in
human PMNL in response to fMLP, C5a and IL-8/NAP-1.
Studies by Metzner et al suggested that this heterogeneity
could be because individual PMNL required different
threshold concentrations of stimulant to induce release of
[Ca2+]i [22]. Yee et al have shown that treatment of PMNL
with lipopolysaccharide (LPS) leads to increase in [Ca2+]i
levels and subsequent stimulation with fMLP resulted in
further elevation of [Ca2+]i. LPS augmented the overall
responsiveness of a population of PMNL by causing a sub-
population of cells to become highly responsive and able
to generate changes in [Ca2+]i upon low level stimulation
Spectrofluorimetric estimation of extent of stimulation of [Ca2+]i in PMNLFigure 5
Spectrofluorimetric estimation of extent of stimulation of [Ca2+]i in PMNL. Extent of stimulation of calcium over 
the basal level in fMLP or C5a stimulated CML and normal PMNL. Ratios of the total calcium in PMNL after stimulation or 
addition of EGTA and MnCl2 to the basal level were calculated. X-axis indicates the treatment given to the cells and Y-axis indi-
cates average of ratios.Page 9 of 14
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mediated signal transduction may be important in the
fine control of the non-specific immune system in
response to weak environmental signals.
The pattern of [Ca2+]i release on fMLP stimulation differed
from that of C5a stimulation. The response to C5a was
delayed as compared to that seen for fMLP. This was true
for both CML and normal PMNL. This could be because
of different time kinetics for internalization and recycling
of FPR and C5aR in human PMNL [24]. We have seen that
in normal PMNL fMLP receptor internalization occurred
by 2–5 min whereas C5a receptor internalization was
delayed and occurred by 5–10 min. The reported values of
Ca2+ in fluo-3 loaded PMNL are 825 ± 94 nM and 798 ±
102 nM on stimulation with fMLP and C5a respectively
[25]. These values are much higher than what we have
obtained. These differences in calcium concentrations
could be due to the differences in the experimental condi-
tions. Moreover, the levels of calcium reported by Lepidi
et al were presumably in the Caucasian population. The
differences in calcium levels could be because of the racial
differences.  
Table 4: Spectrofluorimetric estimation of Ca2+ in C5a stimulated normal and CML PMNL.
Stimulant n Nil (Basal level) C5a
Time 10 s 30 s 60 s EGTA MnCl2
Normal 20 294.81 ± 34.62 524.9# ± 83.11 406.23# ± 3.89 343.22# ± 38.27 358.91 ± 45.82 174.62$ ± 42.88
CML 21 246.86 ± 22.13 558.49# ± 87.80 478.11# ± 3.44 390.70# ± 67.81 387.28# ± 42.06 179.59$ ± 25.64
All values are average ± SEM, in nM. 
n = Number of samples. 
# Significantly higher value over the respective basal level, p < 0.05. 
$ Significantly lower value as compared to the basal level, p < 0.05.
Cartoon depicting Intracellular Ca2+ signalling networkFigure 6
Cartoon depicting Intracellular Ca2+ signalling network. Binding of ligand to the seven transmembrane domain recep-
tors activates release of calcium from intracellular stores through IP3 signalling pathway or ryanodine receptors and also initi-
ates influx of calcium through various channels. Increase in Ca2+ results in various cellular responses.Page 10 of 14
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phosphatases.  Phosphorylation is reported to down reg-
ulate both agonist induced Ca2+ entry and Ca2+ mobiliza-
tion [26]. Bcr-abl, a chimeric protein expressed by the
Philadelphia chromosome has a high and unregulated
tyrosine kinase activity. Many different proteins are aber-
rantly phosphorylated in the cells expressing bcr-abl [27].
Unique phosphatases that can be modulated by α-inter-
feron are also involved in the abnormalities in CML [28].
High phosphotyrosyl phosphatase activity was observed
in PMNL from CML patients in the chronic phase. The
activity may be characteristic of mature cells and may reg-
ulate cellular events through dephosphorylation of
p210bcr-abl [29]. Protein tyrosine phosphatases (PTPs)-
PTP1B is enhanced in cells expressing p210bcr-abl and
has been shown to play a role in dephosphorylation of
p210bcr-abl in vivo. PTP1B may function as a specific,
negative regulator of p210bcr-abl signalling in vivo.
CD45, a family of transmembrane PTPs is expressed in
PMNL. Altered expression of CD45 isoforms has been
reported in myeloid leukaemias [30]. The altered expres-
sion of kinases and phosphatases may alter phosphoryla-
tion of various proteins in CML PMNL. Batliwala et al
have reported altered phosphorylation pattern of proteins
in CML PMNL. In unstimulated CML PMNL, pp1 and pp5
were extensively phosphorylated while phosphorylation
of pp3 had reduced as compared to that in normal PMNL.
Upon PMA stimulation, normal PMNL showed phospho-
rylation of pp1 and pp4. But, in contrast to normal PMNL,
pp1 and pp4 in CML PMNL did not respond to PMA [31].
Additionally, alterations in the surface proteins and glyc-
oproteins of plasma membrane of CML PMNL have been
reported [32,33]. These alterations in various proteins and
enzymes may contribute to the altered Ca2+ homeostasis
in CML PMNL.
Ras related GTPases – rho, rac and cdc42 regulate polym-
erization of actin to produce stress fibres and lamellipodia
[34]. Expression of bcr-abl affects ras and ras related super
family of small GTPases [35,36]. Expression of p210bcr-
abl also resulted in reorganization of the actin cytoskele-
ton in 32DC13 cells [27], suggesting that alteration of ras-
GTPases probably resulted in alteration of actin network.
Altered actin network could affect release of [Ca2+]i from
the intracellular stores and efflux of [Ca2+]i from the cell
cytoplasm. Earlier we have observed that in CML PMNL
actin polymerization in response to chemoattractant stim-
ulation was delayed and significantly lower. Moreover,
distribution of F-actin in CML PMNL was altered as com-
pared to that in normal PMNL [10,12]. Sachhi et al had
reported that PMNL from neonates showed defective
chemotaxis, failure in polymerization of actin and lower
levels of [Ca2+]i, following stimulation with fMLP or
zymosan activated serum [37]. In PMNL, the peripheral
stores of calcium are regulated by the cytoskeletal protein
interactions [18]. In turn, increased [Ca2+]i levels cause
fragmentation of F-actin by activation of actin severing
and capping proteins such as gelsolin and macrophage
capping protein [2]. In view of this, the lower basal levels
of [Ca2+]i and the increased extent of [Ca2+]i release seen in
CML PMNL in response to chemoattractants could be
because of altered regulation of [Ca2+]i stores by altered
actin network.
Mutations or functional abnormalities in the various Ca2+
transporters lead to plethora of diseases. In skeletal mus-
cle pathology, mutations in ryanodine receptors cause
malignant hyperthermia and porcine stress syndrome.
Mutations in calcium pump cause Brody disease. Various
abnormalities in calcium handling proteins have been
reported in the heart during aging, hypertrophy, diabetes,
etc. [38]. Alterations in [Ca2+]i levels of PMNL are associ-
ated with various disorders. Lower [Ca2+]i levels were
observed in PMNL from asthmatic patients, in response to
PAF stimulation [39]. These lower levels of [Ca2+]i were
due to low influx of Ca2+. In localized juvenile periodon-
titis (JP), the basal levels of [Ca2+]i in PMNL were compa-
rable to that of normal. But, fMLP and C5a induced
[Ca2+]i levels were reduced in JP. This was due to decreased
Ca2+ influx. These reduced [Ca2+]i levels were associated
with reduced PKC levels and defective chemotaxis
[40,41]. Similarly in aged individuals, PMNL showed low
[Ca2+]i levels that were associated with defective chemo-
taxis and oxidative burst [42]. Thus, lower [Ca2+]i levels
were often associated with altered chemotaxis. In contrast
to this, calcium transients were not required for other
PMNL functions such as an oxidative burst. For example,
PMNL from Myelodisplastic syndrome (MDS) patients
are defective in respiratory burst. Studies by Nakaseko et
al showed that basal and fMLP stimulated [Ca2+]i levels in
MDS PMNL were comparable to those in normal PMNL
[43]. However, O'Flaherty et al have reported that [Ca2+]i
transients potentiated PMNL degranulation and respira-
tory burst [15]. [Ca2+]i is also known to regulate chemoat-
tractant receptor availability in PMNL. In PMNL from
asthmatic patients, lower [Ca2+]i levels were associated
with lower PAF receptor [39]. O'Flaherty et al have
reported that [Ca2+]i depleted PMNL showed decrease in
receptors for fMLP, LTB4 and PAF [15]. Our studies
showed that though not statistically significant, levels of
[Ca2+]i were lower in unstimulated CML PMNL as com-
pared to normal PMNL. These [Ca2+]i levels in CML PMNL
were lower up to 1 min after stimulation with fMLP and
C5a. However, the total calcium release was more in CML
PMNL than that in normal PMNL. This suggested that
efflux of [Ca2+]i was more and faster in CML PMNL than
that in normal PMNL. Earlier we have shown that CML
PMNL showed a lower number of FPR, defects in actin
and tubulin polymerization, pinocytosis and degranula-
tion. But, stimulation of oxidative burst in CML PMNLPage 11 of 14
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vations are in agreement with earlier reports that [Ca2+]i
levels regulate availability of chemoattractant receptors
and low [Ca2+]i levels are associated with defects in actin
polymerization, chemotaxis and degranulation. However,
[Ca2+]i transients are not essential for stimulation of an
oxidative burst. Additionally our results suggest that the
levels of [Ca2+]i maintained in the cell immediately after
stimulation and not the amount of total calcium released
are important in stimulation of various functional events
in PMNL. PKC is one of the important messengers leading
to various functional events in PMNL. In signal transduc-
tion pathway, PKC is downstream to Ca2+ mobilization.
In CML PMNL, expression of calcium dependent PKC iso-
form α was lowered [44]. Various functional events in
PMNL are mediated partly or totally through PKC. There-
fore, it could be that the defects in various functional
events in CML PMNL are due to alterations in PKC caused
by altered Ca2+ homeostasis or are the direct effect of
altered Ca2+ homeostasis per se.
Conclusion
In summary, our studies show that Ca2+ homeostasis in
CML PMNL is altered. This could be one of the contribut-
ing factors for the reduced responses seen in CML PMNL.
Further studies of the calcium oscillations in CML PMNL
and the Ca-ATPase would help in pin pointing the defects




sulphonic acid (HEPES), ethyleneglycol-bis-(3-aminoe-
thyl)-tetra acetate (EGTA), manganese chloride (MnCl2),
n-formyl-methionyl-leucyl-phenylalanine (fMLP), com-
plement factor 5a (C5a) and Calcium ionophore A23187
were from Sigma. Dimethyl sulfoxide (DMSO) was from
Seezle, Germany. Fluo-3-pentapotassium salt and fluo-
3AM – the pentaacetoxymethyl ester of fluo-3 and cal-
cium calibration kit were from Molecular Probes (Eugene,
USA).
Patients
Patients were diagnosed for CML on the basis of standard
clinical and haematological criteria. Heparinized periph-
eral blood was collected from CML patients in chronic
phase of the disease, before commencement of therapy.
Healthy individuals were used as controls.
Isolation of PMNL
PMNL from peripheral blood were isolated on a ficoll-
hypaque gradient [45]. To lyse RBCs the cell pellet was
given a hypotonic shock using 3 parts of chilled Milli-Q
water. Isotonicity was restored by the addition of 1/3rd
volume of 0.6 M KCl. The PMNL were pelleted and sus-
pended in phosphate buffered saline (PBS). Viability of
cells was more than 99% as checked by the erythrocin B
dye exclusion test. The PMNL fraction was 95% enriched
as checked by Giemsa's staining.
Fluo-3 loading
One millimolar stock solution of fluo-3AM was prepared
in dry DMSO. Fluo-3 loading of PMNL was carried out as
described by Vandenberghe et al with some modifications
[46]. Briefly, PMNL were suspended at a density of 1× 107
cells per ml in fluo-3 loading buffer (10 mM HEPES, 137
mM NaCl, 5 mM KCl, 1 mM Na2HPO4, 5 mM glucose and
0.5 mM MgCl2, pH 7.4) containing 5 μM fluo-3AM.
PMNL were incubated for 30 min at 37°C with gentle agi-
tation. Cells were then washed twice with Ca2+ estimation
buffer (i.e. fluo-3 loading buffer with 1 mM CaCl2) to
remove extra cellular fluo-3AM. Finally the cell density
was adjusted to 1 × 107 cells per ml in the calcium estima-
tion buffer. The cells were kept in dark at 4°C till use.
Measurement of [Ca2+]i by flow cytometry
106 PMNL were suspended in one ml Ca2+ estimation
buffer and incubated in a 37°C water bath, for 5 min
before each assay. The samples were run on FACScalibur
(Becton-Dickinson, USA) using Cell-Quest software. The
samples were excited by an argon ion laser at 488 nm and
emission was measured at 525 nm on a logarithmic scale.
Before addition of the stimuli, fluorescence of the fluo-3
loaded PMNL was measured. Optimum stimulation of
PMNL in suspension with fMLP was seen at a concentra-
tion of 10-8 M [10,11] whereas with C5a it was seen at 10
fold lower concentration [47]. Therefore, PMNL were
stimulated with 10-8 M fMLP and 10-9 M C5a. Fluores-
cence was estimated at 10 sec, 30 sec and 60 sec after addi-
tion of the stimuli. For each acquisition, minimum 5000
events were collected. Fmax was estimated using PMNL
treated with calcium ionophore A23187. Quenching of
external and internal fluo-3 fluorescence was estimated
using 0.4 M EGTA and 2 mM MnCl2, respectively. Median
channel number was taken as a measure of fluorescence
intensity of the sample.
Calibration procedure
To convert the arbitrary fluorescence units of fluorescence
measured by spectrofluorimeter into absolute Ca2+, a cal-
ibration procedure described by Vandenberghe was used
[46]. The dissociation constant, i.e. Kd for Ca2+ bound
fluo-3 was calculated using calibration kit. The maximum
concentration of Ca2+ in the kit, i.e. 39.8 μM was taken as
Fmax and buffer without Ca2+ was taken as Fmin. The cal-
cium bound fluo-3 and free fluo-3 both showed excitation
and emission peak at 506 nm and 526 nm, respectively.
Therefore, Kd of fluo-3 was calculated by measuring fluo-
rescence of fluo-3 pentapotassium salt (5 μM) using these
excitation and emission wavelengths on a ShimadzuPage 12 of 14
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tained at 37°C.
The Kd of fluo-3 was calculated using the equation:
Kd = [Ca2+]i/[(F-Fmin)/(Fmax-F)]  equation I [48]
The experiment was done four times independently.
Measurement of total Ca2+ by spectrofluorimetry
106 fluo-3 loaded PMNL were suspended in two ml Ca2+
estimation buffer and incubated in a water bath at 37°C
for 5 min, before each assay. PMNL were then stimulated
with 10-8 M fMLP or 10-9 M C5a. The fluorimetric reading
was taken before stimulation and at 10 sec, 30 sec and 60
sec after stimulation.
Autofluorescence was calculated using unloaded PMNL.
Fmax, the maximum fluorescence was obtained by treating
the cells with 10 μM of calcium ionophore A23187. F rep-
resents the fluorescence of the test sample. Quenching of
external and internal fluo-3 fluorescence was estimated
using 0.4 M EGTA and 2 mM MnCl2, respectively. Fluo-3-
Mn2+ complex is eight times less fluorescent as compared
to fluo-3-Ca2+ complex. Under experimental conditions,
the quenching of fluo-3 by MnCl2 was low as compared to
autofluorescence of PMNL, hence autofluorescence was
considered as Fmin [49]. The spectrofluorimetric values
were converted to concentration of Ca2+ by using equation
I.
Statistical analysis
Non-parametric tests were applied for statistical analysis
of the data. Wilcoxon signed rank test was used to com-
pare the median fluorescence channel and absolute cal-
cium concentrations within normal and CML samples.
The Mann-Whitney Wilcoxon test was used to compare
the median fluorescence channel and absolute calcium
concentrations of normal and CML samples. The Mann-
Whitney Wilcoxon test was also used to compare the
median fluorescence channel and absolute calcium con-
centration values of fMLP stimulated PMNL with that of
C5a stimulated PMNL.
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